AI-driven diagnostic and monitoring technology for COPD and asthma.
| Date | Round | Amount |
|---|---|---|
| Jul 2026 | Funding round Cambridge respiratory diagnostics company TidalSense raised a 16.6 million euro round to commercialise its AI breath-analysis device in the UK and expand internationally, including to the US. New investor Cross-Border Impact Ventures joined returning backers. | $19M |
| May 2023 | Funding round Cambridge healthtech TidalSense raised £7.5M led by BGF and Downing for its AI respiratory diagnostics. | $9.5M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.